Vanguard Group’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$432M Buy
8,847,467
+240,095
+3% +$11.7M 0.01% 1112
2025
Q1
$439M Sell
8,607,372
-571,450
-6% -$29.1M 0.01% 1067
2024
Q4
$414M Buy
9,178,822
+53,688
+0.6% +$2.42M 0.01% 1148
2024
Q3
$339M Buy
9,125,134
+151,363
+2% +$5.62M 0.01% 1257
2024
Q2
$274M Sell
8,973,771
-395,243
-4% -$12.1M 0.01% 1320
2024
Q1
$273M Buy
9,369,014
+568,171
+6% +$16.5M 0.01% 1333
2023
Q4
$243M Buy
8,800,843
+855,354
+11% +$23.6M 0.01% 1399
2023
Q3
$178M Buy
7,945,489
+393,012
+5% +$8.81M ﹤0.01% 1491
2023
Q2
$307M Sell
7,552,477
-35,305
-0.5% -$1.44M 0.01% 1230
2023
Q1
$368M Buy
7,587,782
+248,262
+3% +$12M 0.01% 1081
2022
Q4
$280M Buy
7,339,520
+127,800
+2% +$4.88M 0.01% 1234
2022
Q3
$362M Buy
7,211,720
+28,028
+0.4% +$1.41M 0.01% 1029
2022
Q2
$288M Buy
7,183,692
+250,616
+4% +$10M 0.01% 1195
2022
Q1
$259M Buy
6,933,076
+44,167
+0.6% +$1.65M 0.01% 1383
2021
Q4
$274M Buy
6,888,909
+130,935
+2% +$5.22M 0.01% 1407
2021
Q3
$251M Buy
6,757,974
+23,344
+0.3% +$869K 0.01% 1457
2021
Q2
$285M Buy
6,734,630
+345,774
+5% +$14.6M 0.01% 1401
2021
Q1
$303M Buy
6,388,856
+187,889
+3% +$8.9M 0.01% 1299
2020
Q4
$378M Buy
6,200,967
+373,155
+6% +$22.8M 0.01% 1042
2020
Q3
$272M Buy
5,827,812
+155,476
+3% +$7.27M 0.01% 1064
2020
Q2
$288M Buy
5,672,336
+93,165
+2% +$4.73M 0.01% 1050
2020
Q1
$249M Buy
5,579,171
+137,531
+3% +$6.14M 0.01% 1006
2019
Q4
$261M Buy
5,441,640
+271,648
+5% +$13M 0.01% 1232
2019
Q3
$175M Buy
5,169,992
+99,318
+2% +$3.36M 0.01% 1411
2019
Q2
$228M Buy
5,070,674
+102,485
+2% +$4.61M 0.01% 1279
2019
Q1
$187M Buy
4,968,189
+372,084
+8% +$14M 0.01% 1387
2018
Q4
$158M Buy
4,596,105
+137,810
+3% +$4.73M 0.01% 1399
2018
Q3
$210M Buy
4,458,295
+1,261,166
+39% +$59.3M 0.01% 1354
2018
Q2
$108M Buy
3,197,129
+236,465
+8% +$7.98M ﹤0.01% 1740
2018
Q1
$80.1M Buy
2,960,664
+185,009
+7% +$5.01M ﹤0.01% 1830
2017
Q4
$46.3M Sell
2,775,655
-159,638
-5% -$2.66M ﹤0.01% 2096
2017
Q3
$58.7M Buy
2,935,293
+568,729
+24% +$11.4M ﹤0.01% 1961
2017
Q2
$43.4M Buy
2,366,564
+346,525
+17% +$6.35M ﹤0.01% 2080
2017
Q1
$19.9M Buy
2,020,039
+101,331
+5% +$997K ﹤0.01% 2447
2016
Q4
$20.9M Buy
1,918,708
+69,261
+4% +$756K ﹤0.01% 2404
2016
Q3
$25.9M Sell
1,849,447
-480,355
-21% -$6.73M ﹤0.01% 2251
2016
Q2
$16.4M Buy
2,329,802
+269,642
+13% +$1.89M ﹤0.01% 2413
2016
Q1
$13.3M Buy
2,060,160
+13,784
+0.7% +$88.8K ﹤0.01% 2463
2015
Q4
$66.3M Buy
2,046,376
+54,416
+3% +$1.76M ﹤0.01% 1744
2015
Q3
$53.2M Buy
1,991,960
+271,569
+16% +$7.25M ﹤0.01% 1835
2015
Q2
$82.8M Buy
1,720,391
+89,754
+6% +$4.32M 0.01% 1643
2015
Q1
$99.2M Buy
1,630,637
+455,461
+39% +$27.7M 0.01% 1504
2014
Q4
$60.8M Buy
1,175,176
+609,178
+108% +$31.5M ﹤0.01% 1727
2014
Q3
$24.9M Buy
565,998
+17,194
+3% +$757K ﹤0.01% 2111
2014
Q2
$14.3M Buy
548,804
+82,849
+18% +$2.17M ﹤0.01% 2354
2014
Q1
$12.2M Buy
465,955
+318,506
+216% +$8.33M ﹤0.01% 2397
2013
Q4
$2.5M Buy
147,449
+92,261
+167% +$1.57M ﹤0.01% 3101
2013
Q3
$1.18M Buy
+55,188
New +$1.18M ﹤0.01% 3326